Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

Lior mor

355 POSTS

Exclusive articles:

Quantumsphere Acquisition (QUMSU): A New SPAC Enters the Arena with $72 Million IPO and Big Promises

Quantumsphere Acquisition Corporation, a newly formed SPAC, has made its debut on the Nasdaq with an upsized $72 million IPO, positioning itself as a...

Bullish IPO: Inside the $4.3 Billion Crypto Exchange Listing on the NYSE

In a bold move signaling renewed institutional appetite for crypto infrastructure, Bullish, a Cayman Islands–based digital asset exchange, has filed for a $599 million...

Figma’s Historic IPO Ignites Tech Hype as U.S. Listings Rebound Sharply

A powerful week in the U.S. IPO market saw seven companies debut, with software giant Figma stealing the spotlight in what is now considered...

Dakota Gold Corp. (DKNX): Mining for Value in the 2025 IPO Landscape

New Gold, Old Story—Dakota Gold’s Public Debut in a Volatile Commodities Market As global markets experience renewed volatility in 2025, investor appetite for precious metals...

TechCreate Group Files for $11M IPO: Southeast Asia’s Fintech Challenger Targets NYSE Listing

A New Singaporean Player Eyes the U.S. Market TechCreate Group, a Singapore-based distributor of software and digital payment solutions, has officially filed with the SEC...

Breaking

SKN | Geothermal Developer Fervo Energy Files for Estimated $250 Million IPO

Fervo Energy, a next-generation geothermal energy developer, has filed...

SKN | Mobia Medical Files for $100M IPO as Neurostimulation Therapy Targets $30B Stroke Market

FDA-Approved Device Positions Company in High-Value Neurorehabilitation Segment Mobia Medical...

SKN | Amatuhi Holdings Raises IPO Range as Investor Demand Lifts Expected Proceeds by 60%

Revised Pricing Signals Stronger Market Interest Ahead of Nasdaq...

SKN | Alamar Biosciences Prices Upsized IPO at $17, the High End of the Range

Alamar Biosciences has priced its upsized initial public offering...
spot_imgspot_img